{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T00:24:27Z","timestamp":1787444667314,"version":"build-2736575974"},"reference-count":47,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2018,9,19]],"date-time":"2018-09-19T00:00:00Z","timestamp":1537315200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81220108020"],"award-info":[{"award-number":["81220108020"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81501848"],"award-info":[{"award-number":["81501848"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81672125"],"award-info":[{"award-number":["81672125"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy Nucleic Acids"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1016\/j.omtn.2018.09.012","type":"journal-article","created":{"date-parts":[[2018,9,22]],"date-time":"2018-09-22T05:04:56Z","timestamp":1537592696000},"page":"291-302","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"special_numbering":"C","title":["Adeno-Associated Virus-Mediated RNAi against Mutant Alleles Attenuates Abnormal Calvarial Phenotypes in an Apert Syndrome Mouse Model"],"prefix":"10.1016","volume":"13","author":[{"given":"Fengtao","family":"Luo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yangli","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zuqiang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junlan","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiaoyan","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xianding","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fangfang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Can","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mi","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dali","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meng","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nan","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenhong","family":"Ni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wanling","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinhong","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hangang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuai","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoling","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chuxia","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhugang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaolan","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.omtn.2018.09.012_bib1","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.ajhg.2015.07.006","article-title":"A Genetic-Pathophysiological Framework for Craniosynostosis","volume":"97","author":"Twigg","year":"2015","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.omtn.2018.09.012_bib2","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.7150\/ijbs.22373","article-title":"Fibroblast growth factor receptor 2 (FGFR2) mutation related syndromic craniosynostosis","volume":"13","author":"Azoury","year":"2017","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.omtn.2018.09.012_bib3","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1006\/mgme.1999.2915","article-title":"Craniosynostosis syndromes: from genes to premature fusion of skull bones","volume":"68","author":"Hehr","year":"1999","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.omtn.2018.09.012_bib4","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1038\/ng0295-165","article-title":"Apert syndrome results from localized mutations of FGFR2 and is allelic with Crouzon syndrome","volume":"9","author":"Wilkie","year":"1995","journal-title":"Nat. Genet."},{"key":"10.1016\/j.omtn.2018.09.012_bib5","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1093\/hmg\/6.1.137","article-title":"Genotype-phenotype correlation for nucleotide substitutions in the IgII-IgIII linker of FGFR2","volume":"6","author":"Oldridge","year":"1997","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.omtn.2018.09.012_bib6","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/S8756-3282(03)00222-9","article-title":"A Ser252Trp [corrected] substitution in mouse fibroblast growth factor receptor 2 (Fgfr2) results in craniosynostosis","volume":"33","author":"Chen","year":"2003","journal-title":"Bone"},{"key":"10.1016\/j.omtn.2018.09.012_bib7","doi-asserted-by":"crossref","first-page":"3537","DOI":"10.1242\/dev.01914","article-title":"Abnormalities in cartilage and bone development in the Apert syndrome FGFR2(+\/S252W) mouse","volume":"132","author":"Wang","year":"2005","journal-title":"Development"},{"key":"10.1016\/j.omtn.2018.09.012_bib8","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/j.bone.2007.11.019","article-title":"A Pro253Arg mutation in fibroblast growth factor receptor 2 (Fgfr2) causes skeleton malformation mimicking human Apert syndrome by affecting both chondrogenesis and osteogenesis","volume":"42","author":"Yin","year":"2008","journal-title":"Bone"},{"key":"10.1016\/j.omtn.2018.09.012_bib9","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/1471-213X-10-22","article-title":"Activation of p38 MAPK pathway in the skull abnormalities of Apert syndrome Fgfr2(+P253R) mice","volume":"10","author":"Wang","year":"2010","journal-title":"BMC Dev. Biol."},{"key":"10.1016\/j.omtn.2018.09.012_bib10","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.ydbio.2009.01.026","article-title":"Early onset of craniosynostosis in an Apert mouse model reveals critical features of this pathology","volume":"328","author":"Holmes","year":"2009","journal-title":"Dev. Biol."},{"key":"10.1016\/j.omtn.2018.09.012_bib11","first-page":"97","article-title":"Dynamic morphological changes in the skulls of mice mimicking human Apert syndrome resulting from gain-of-function mutation of FGFR2 (P253R)","volume":"217","author":"Du","year":"2010","journal-title":"J.\u00a0Anat."},{"key":"10.1016\/j.omtn.2018.09.012_bib12","doi-asserted-by":"crossref","first-page":"32","DOI":"10.7150\/ijbs.16287","article-title":"Deformed Skull Morphology Is Caused by the Combined Effects of the Maldevelopment of Calvarias, Cranial Base and Brain in FGFR2-P253R Mice Mimicking Human Apert Syndrome","volume":"13","author":"Luo","year":"2017","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.omtn.2018.09.012_bib13","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1002\/dvdy.22218","article-title":"Brain phenotypes in two FGFR2 mouse models for Apert syndrome","volume":"239","author":"Aldridge","year":"2010","journal-title":"Dev. Dyn."},{"key":"10.1016\/j.omtn.2018.09.012_bib14","doi-asserted-by":"crossref","first-page":"3058","DOI":"10.1002\/dvdy.22414","article-title":"Beyond the closed suture in apert syndrome mouse models: evidence of primary effects of FGFR2 signaling on facial shape at birth","volume":"239","author":"Mart\u00ednez-Abad\u00edas","year":"2010","journal-title":"Dev. Dyn."},{"key":"10.1016\/j.omtn.2018.09.012_bib15","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1016\/j.bone.2010.11.014","article-title":"The primary site of the acrocephalic feature in Apert Syndrome is a dwarf cranial base with accelerated chondrocytic differentiation due to aberrant activation of the FGFR2 signaling","volume":"48","author":"Nagata","year":"2011","journal-title":"Bone"},{"key":"10.1016\/j.omtn.2018.09.012_bib16","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1038\/ng2096","article-title":"RNA interference and inhibition of MEK-ERK signaling prevent abnormal skeletal phenotypes in a mouse model of craniosynostosis","volume":"39","author":"Shukla","year":"2007","journal-title":"Nat. Genet."},{"key":"10.1016\/j.omtn.2018.09.012_bib17","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1016\/j.jcms.2016.06.001","article-title":"Apert syndrome: Surgical outcomes and perspectives","volume":"44","author":"Breik","year":"2016","journal-title":"J.\u00a0Craniomaxillofac. Surg."},{"key":"10.1016\/j.omtn.2018.09.012_bib18","doi-asserted-by":"crossref","first-page":"E2","DOI":"10.3171\/2015.2.FOCUS155","article-title":"Insights into the development of molecular therapies for craniosynostosis","volume":"38","author":"Kosty","year":"2015","journal-title":"Neurosurg. Focus"},{"key":"10.1016\/j.omtn.2018.09.012_bib19","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1002\/dvdy.24099","article-title":"Soluble form of FGFR2 with S252W partially prevents craniosynostosis of the apert mouse model","volume":"243","author":"Morita","year":"2014","journal-title":"Dev. Dyn."},{"key":"10.1016\/j.omtn.2018.09.012_bib20","doi-asserted-by":"crossref","first-page":"e101693","DOI":"10.1371\/journal.pone.0101693","article-title":"Therapeutic effect of nanogel-based delivery of soluble FGFR2 with S252W mutation on craniosynostosis","volume":"9","author":"Yokota","year":"2014","journal-title":"PLoS ONE"},{"key":"10.1016\/j.omtn.2018.09.012_bib21","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1038\/nm.3791","article-title":"Aptamer-functionalized lipid nanoparticles targeting osteoblasts as a novel RNA interference-based bone anabolic strategy","volume":"21","author":"Liang","year":"2015","journal-title":"Nat. Med."},{"key":"10.1016\/j.omtn.2018.09.012_bib22","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1126\/science.1236921","article-title":"Allele-specific silencing of mutant Myh6 transcripts in mice suppresses hypertrophic cardiomyopathy","volume":"342","author":"Jiang","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.omtn.2018.09.012_bib23","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1161\/CIRCRESAHA.117.310882","article-title":"Allele-Specific Silencing of Mutant mRNA Rescues Ultrastructural and Arrhythmic Phenotype in Mice Carriers of the R4496C Mutation in the Ryanodine Receptor Gene (RYR2)","volume":"121","author":"Bongianino","year":"2017","journal-title":"Circ. Res."},{"key":"10.1016\/j.omtn.2018.09.012_bib24","doi-asserted-by":"crossref","first-page":"a003640","DOI":"10.1101\/cshperspect.a003640","article-title":"In\u00a0vivo RNAi: today and tomorrow","volume":"2","author":"Perrimon","year":"2010","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"10.1016\/j.omtn.2018.09.012_bib25","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.gene.2013.12.019","article-title":"Therapeutic potentials of gene silencing by RNA interference: principles, challenges, and new strategies","volume":"538","author":"Deng","year":"2014","journal-title":"Gene"},{"key":"10.1016\/j.omtn.2018.09.012_bib26","first-page":"158","article-title":"RNAi therapeutics: an update on delivery","volume":"10","author":"Nguyen","year":"2008","journal-title":"Curr. Opin. Mol. Ther."},{"key":"10.1016\/j.omtn.2018.09.012_bib27","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1038\/mt.2008.76","article-title":"Analysis of AAV serotypes 1-9 mediated gene expression and tropism in mice after systemic injection","volume":"16","author":"Zincarelli","year":"2008","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtn.2018.09.012_bib28","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1038\/nrg3742","article-title":"Engineering adeno-associated viruses for clinical gene therapy","volume":"15","author":"Kotterman","year":"2014","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.omtn.2018.09.012_bib29","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1089\/hum.2016.171","article-title":"Future of rAAV Gene Therapy: Platform for RNAi, Gene Editing, and Beyond","volume":"28","author":"Valdmanis","year":"2017","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.omtn.2018.09.012_bib30","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1016\/S0006-291X(03)01429-3","article-title":"Adeno-associated virus-mediated bone morphogenetic protein-4 gene therapy for in\u00a0vivo bone formation","volume":"308","author":"Luk","year":"2003","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.omtn.2018.09.012_bib31","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/j.ymthe.2003.12.009","article-title":"Gene therapy platform for bone regeneration using an exogenously regulated, AAV-2-based gene expression system","volume":"9","author":"Gafni","year":"2004","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtn.2018.09.012_bib32","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1038\/ejhg.2010.235","article-title":"Craniosynostosis","volume":"19","author":"Johnson","year":"2011","journal-title":"Eur. J. Hum. Genet."},{"key":"10.1016\/j.omtn.2018.09.012_bib33","doi-asserted-by":"crossref","first-page":"103","DOI":"10.4161\/org.23307","article-title":"Craniosynostosis: molecular pathways and future pharmacologic therapy","volume":"8","author":"Senarath-Yapa","year":"2012","journal-title":"Organogenesis"},{"key":"10.1016\/j.omtn.2018.09.012_bib34","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.7150\/ijbs.20792","article-title":"Fibroblast Growth Factor Receptor 2 Signaling in Breast Cancer","volume":"13","author":"Lei","year":"2017","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.omtn.2018.09.012_bib35","doi-asserted-by":"crossref","first-page":"2180","DOI":"10.1038\/nprot.2013.132","article-title":"CRISPR interference (CRISPRi) for sequence-specific control of gene expression","volume":"8","author":"Larson","year":"2013","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.omtn.2018.09.012_bib36","first-page":"267","article-title":"Update on the clinical utility of an RNA interference-based treatment: focus on Patisiran","volume":"10","author":"Rizk","year":"2017","journal-title":"Pharm. Genomics Pers. Med."},{"key":"10.1016\/j.omtn.2018.09.012_bib37","doi-asserted-by":"crossref","first-page":"e140","DOI":"10.1371\/journal.pgen.0020140","article-title":"Designing siRNA that distinguish between genes that differ by a single nucleotide","volume":"2","author":"Schwarz","year":"2006","journal-title":"PLoS Genet."},{"key":"10.1016\/j.omtn.2018.09.012_bib38","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1038\/nsmb780","article-title":"Kinetic analysis of the RNAi enzyme complex","volume":"11","author":"Haley","year":"2004","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.omtn.2018.09.012_bib39","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1002\/jor.20860","article-title":"Biological activation of bone-related biomaterials by recombinant adeno-associated virus vector","volume":"27","author":"Nasu","year":"2009","journal-title":"J.\u00a0Orthop. Res."},{"key":"10.1016\/j.omtn.2018.09.012_bib40","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1038\/sj.gt.3301999","article-title":"Gene therapy for new bone formation using adeno-associated viral bone morphogenetic protein-2 vectors","volume":"10","author":"Chen","year":"2003","journal-title":"Gene Ther."},{"key":"10.1016\/j.omtn.2018.09.012_bib41","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/j.bbrc.2004.03.098","article-title":"Combination of adeno-associated virus and adenovirus vectors expressing bone morphogenetic protein-2 produces enhanced osteogenic activity in immunocompetent rats","volume":"317","author":"Chen","year":"2004","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.omtn.2018.09.012_bib42","doi-asserted-by":"crossref","first-page":"5080","DOI":"10.1093\/nar\/23.24.5080","article-title":"A cre-transgenic mouse strain for the ubiquitous deletion of loxP-flanked gene segments including deletion in germ cells","volume":"23","author":"Schwenk","year":"1995","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.omtn.2018.09.012_bib43","first-page":"183","article-title":"Assessing bone formation using mouse calvarial organ cultures","volume":"80","author":"Garrett","year":"2003","journal-title":"Methods Mol. Med."},{"key":"10.1016\/j.omtn.2018.09.012_bib44","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.bone.2014.03.003","article-title":"Morphological comparison of the craniofacial phenotypes of mouse models expressing the Apert FGFR2 S252W mutation in neural crest- or mesoderm-derived tissues","volume":"63","author":"Heuz\u00e9","year":"2014","journal-title":"Bone"},{"key":"10.1016\/j.omtn.2018.09.012_bib45","first-page":"39","article-title":"Analysis of craniofacial growth in Crouzon syndrome using landmark data","volume":"10","author":"Richtsmeier","year":"1990","journal-title":"J.\u00a0Craniofac. Genet. Dev. Biol."},{"key":"10.1016\/j.omtn.2018.09.012_bib46","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/ajpa.1330980107","article-title":"Euclidean distance matrix analysis: confidence intervals for form and growth differences","volume":"98","author":"Lele","year":"1995","journal-title":"Am. J. Phys. Anthropol."},{"key":"10.1016\/j.omtn.2018.09.012_bib47","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1002\/(SICI)1097-0177(200002)217:2<137::AID-DVDY1>3.0.CO;2-N","article-title":"Parallels of craniofacial maldevelopment in Down syndrome and Ts65Dn mice","volume":"217","author":"Richtsmeier","year":"2000","journal-title":"Dev. Dyn."}],"container-title":["Molecular Therapy Nucleic Acids"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2162253118302567?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2162253118302567?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,8]],"date-time":"2025-11-08T11:22:55Z","timestamp":1762600975000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2162253118302567"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12]]},"references-count":47,"alternative-id":["S2162253118302567"],"URL":"https:\/\/doi.org\/10.1016\/j.omtn.2018.09.012","relation":{},"ISSN":["2162-2531"],"issn-type":[{"value":"2162-2531","type":"print"}],"subject":[],"published":{"date-parts":[[2018,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Adeno-Associated Virus-Mediated RNAi against Mutant Alleles Attenuates Abnormal Calvarial Phenotypes in an Apert Syndrome Mouse Model","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy Nucleic Acids","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.omtn.2018.09.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 The Author(s).","name":"copyright","label":"Copyright"}]}}